Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01566721
Brief Title: A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (SafeHER)

First Submitted : March 22, 2012
First Submitted that Met QC Criteria : March 27, 2012
First Posted : March 29, 2012 (Estimate)

Results First Submitted : March 6, 2017
Results First Submitted that Met QC Criteria : March 6, 2017
Results First Posted : April 18, 2017

Last Update Submitted that Met QC Criteria : May 13, 2020
Last Update Posted : May 27, 2020